<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:f577df7a-ce81-444c-bcac-69cc584d2787,g:6f50112e-4d90-4864-a237-7e37c673f428-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtvt-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1d19c063-15d4-411a-962a-25a65b8f7e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1a4b7ab3-5dec-4e9a-a095-529b62367857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1d19c063-15d4-411a-962a-25a65b8f7e0d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1a4b7ab3-5dec-4e9a-a095-529b62367857" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7caeb366-d86a-4e02-bbef-a84f88caf798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1d19c063-15d4-411a-962a-25a65b8f7e0d" xlink:to="loc_us-gaap_LiabilitiesCurrent_7caeb366-d86a-4e02-bbef-a84f88caf798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_548a2979-fab4-49f0-a45b-48758528da6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1d19c063-15d4-411a-962a-25a65b8f7e0d" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_548a2979-fab4-49f0-a45b-48758528da6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_5f444fde-796f-4c9a-bc0f-119c2671ff9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1d19c063-15d4-411a-962a-25a65b8f7e0d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_5f444fde-796f-4c9a-bc0f-119c2671ff9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1eefd0f5-7019-4a35-bc2b-5b340fff3aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_830da9ac-e320-4351-9908-0d3003b5e66e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1eefd0f5-7019-4a35-bc2b-5b340fff3aeb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_830da9ac-e320-4351-9908-0d3003b5e66e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_782ad094-a2e1-49d8-8b09-223acab5124b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1eefd0f5-7019-4a35-bc2b-5b340fff3aeb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_782ad094-a2e1-49d8-8b09-223acab5124b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bba70529-94a2-4e58-96cb-e46bddaad29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1eefd0f5-7019-4a35-bc2b-5b340fff3aeb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bba70529-94a2-4e58-96cb-e46bddaad29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_1ba89808-c82f-4adc-977e-a1b3842090b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1eefd0f5-7019-4a35-bc2b-5b340fff3aeb" xlink:to="loc_us-gaap_NotesPayableCurrent_1ba89808-c82f-4adc-977e-a1b3842090b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_965f1c24-949e-4674-bc9a-ee6739ca6d37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3041d96f-2d70-48eb-b535-bcc0ee4011b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_965f1c24-949e-4674-bc9a-ee6739ca6d37" xlink:to="loc_us-gaap_CommonStockValue_3041d96f-2d70-48eb-b535-bcc0ee4011b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_eacf140f-1179-4240-9bee-2fd60ff37077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_965f1c24-949e-4674-bc9a-ee6739ca6d37" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_eacf140f-1179-4240-9bee-2fd60ff37077" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f70e2b1c-8f81-438a-b53e-fe9709538351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_965f1c24-949e-4674-bc9a-ee6739ca6d37" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f70e2b1c-8f81-438a-b53e-fe9709538351" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_adcfb2d3-c206-4b7c-8cd9-93cd592590f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_47882dd7-e403-436f-8b5e-194cd0e1f2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_adcfb2d3-c206-4b7c-8cd9-93cd592590f9" xlink:to="loc_us-gaap_AssetsCurrent_47882dd7-e403-436f-8b5e-194cd0e1f2d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f68c0068-a017-44f4-8338-3123e0e224f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_adcfb2d3-c206-4b7c-8cd9-93cd592590f9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f68c0068-a017-44f4-8338-3123e0e224f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0cd6e441-0040-426b-8333-65959ea52df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_adcfb2d3-c206-4b7c-8cd9-93cd592590f9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0cd6e441-0040-426b-8333-65959ea52df9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_c21b5088-0ec3-4600-9ea9-1a31e83af2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_adcfb2d3-c206-4b7c-8cd9-93cd592590f9" xlink:to="loc_us-gaap_LongTermInvestments_c21b5088-0ec3-4600-9ea9-1a31e83af2fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_51460c20-8110-4c1e-83a4-2a0ef4056940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3cf6e88e-2522-42c7-a8e5-1bbfe0f09d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51460c20-8110-4c1e-83a4-2a0ef4056940" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3cf6e88e-2522-42c7-a8e5-1bbfe0f09d77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a9c8ed6f-a933-487f-8952-9d44ba9ab697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51460c20-8110-4c1e-83a4-2a0ef4056940" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a9c8ed6f-a933-487f-8952-9d44ba9ab697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_5ba86e86-0e5d-4e78-89c5-b150bb834365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51460c20-8110-4c1e-83a4-2a0ef4056940" xlink:to="loc_us-gaap_DepositsAssetsCurrent_5ba86e86-0e5d-4e78-89c5-b150bb834365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_NotesReceivableCurrent_5c9600a2-3cdb-46e1-838f-bc3c7f63f476" xlink:href="vtvt-20221231.xsd#vtvt_NotesReceivableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51460c20-8110-4c1e-83a4-2a0ef4056940" xlink:to="loc_vtvt_NotesReceivableCurrent_5c9600a2-3cdb-46e1-838f-bc3c7f63f476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8479d5bb-2799-4db5-afb3-3dc9e609f068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51460c20-8110-4c1e-83a4-2a0ef4056940" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8479d5bb-2799-4db5-afb3-3dc9e609f068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8031beb6-a953-47c6-946b-c9034c1c4984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1c571afc-e68a-4893-b8d4-0cd3e10624c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8031beb6-a953-47c6-946b-c9034c1c4984" xlink:to="loc_us-gaap_Liabilities_1c571afc-e68a-4893-b8d4-0cd3e10624c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_cae94f05-5005-4aa3-866e-dd91f2a7ef75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8031beb6-a953-47c6-946b-c9034c1c4984" xlink:to="loc_us-gaap_CommitmentsAndContingencies_cae94f05-5005-4aa3-866e-dd91f2a7ef75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b8078958-aab7-42ae-b09b-71788cc0f499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8031beb6-a953-47c6-946b-c9034c1c4984" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b8078958-aab7-42ae-b09b-71788cc0f499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f850b726-f3b9-450b-a993-a50e9f99632c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8031beb6-a953-47c6-946b-c9034c1c4984" xlink:to="loc_us-gaap_StockholdersEquity_f850b726-f3b9-450b-a993-a50e9f99632c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vtvt-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94338cc5-cb1d-41a5-a321-2c0cf15cfcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3bf08aa3-3b91-4072-85b4-dc20b3e6d7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94338cc5-cb1d-41a5-a321-2c0cf15cfcb4" xlink:to="loc_us-gaap_OperatingIncomeLoss_3bf08aa3-3b91-4072-85b4-dc20b3e6d7ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2f2332db-67bf-4697-8743-2185ca124c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94338cc5-cb1d-41a5-a321-2c0cf15cfcb4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2f2332db-67bf-4697-8743-2185ca124c51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_OtherIncomeExpensesRelatedParty_1bcdbe1c-c6f5-4653-b05c-f7cf79cf857a" xlink:href="vtvt-20221231.xsd#vtvt_OtherIncomeExpensesRelatedParty"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94338cc5-cb1d-41a5-a321-2c0cf15cfcb4" xlink:to="loc_vtvt_OtherIncomeExpensesRelatedParty_1bcdbe1c-c6f5-4653-b05c-f7cf79cf857a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_81020385-6241-4e52-b2be-5a7590914695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94338cc5-cb1d-41a5-a321-2c0cf15cfcb4" xlink:to="loc_us-gaap_InvestmentIncomeInterest_81020385-6241-4e52-b2be-5a7590914695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ac2c6427-54fb-41e0-b7fa-4fce2a0b7a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94338cc5-cb1d-41a5-a321-2c0cf15cfcb4" xlink:to="loc_us-gaap_InterestExpense_ac2c6427-54fb-41e0-b7fa-4fce2a0b7a02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bd38b409-573f-4f88-a53e-9cb91064c902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_05cb6e4e-d220-4adc-9cb8-ee8c088bec1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bd38b409-573f-4f88-a53e-9cb91064c902" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_05cb6e4e-d220-4adc-9cb8-ee8c088bec1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_42e11008-a751-44b5-97f9-133c372e3ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bd38b409-573f-4f88-a53e-9cb91064c902" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_42e11008-a751-44b5-97f9-133c372e3ce2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9cab2048-fd40-4d22-baa5-4ab6352fdbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6ea53578-2e3d-41f0-b6d4-5970d66935bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9cab2048-fd40-4d22-baa5-4ab6352fdbf9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6ea53578-2e3d-41f0-b6d4-5970d66935bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_874a84f8-76cb-4190-a27d-b272f064e9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9cab2048-fd40-4d22-baa5-4ab6352fdbf9" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_874a84f8-76cb-4190-a27d-b272f064e9b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_903e74e0-ab01-4de7-a49d-d33d06618570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e2859a40-92fc-4000-8d0b-aa7f5b21652b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_903e74e0-ab01-4de7-a49d-d33d06618570" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e2859a40-92fc-4000-8d0b-aa7f5b21652b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d451cec8-5108-473d-a269-4a05fd9a9bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_903e74e0-ab01-4de7-a49d-d33d06618570" xlink:to="loc_us-gaap_OperatingExpenses_d451cec8-5108-473d-a269-4a05fd9a9bc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_35a54931-b192-4d34-b767-aba759950a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_09cc5684-3f11-4422-a3b4-874c088bcf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_35a54931-b192-4d34-b767-aba759950a8d" xlink:to="loc_us-gaap_ProfitLoss_09cc5684-3f11-4422-a3b4-874c088bcf0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b57b2f21-3ec8-4eaf-8843-4a35f4412394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_35a54931-b192-4d34-b767-aba759950a8d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b57b2f21-3ec8-4eaf-8843-4a35f4412394" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="vtvt-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_717a88e6-6e77-4f29-9246-e6b454c765e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c586fbe-6131-440a-b64d-83be79cea21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_717a88e6-6e77-4f29-9246-e6b454c765e5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c586fbe-6131-440a-b64d-83be79cea21a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_647759a1-f72f-4bc0-815d-06f83e7daad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_717a88e6-6e77-4f29-9246-e6b454c765e5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_647759a1-f72f-4bc0-815d-06f83e7daad3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4a2d6892-c03b-4c71-a834-82743c13b8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_717a88e6-6e77-4f29-9246-e6b454c765e5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4a2d6892-c03b-4c71-a834-82743c13b8ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed3caba7-9625-4f40-819d-32240dd9efee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0d06dc56-e85b-4fda-a6e2-e8101876c028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed3caba7-9625-4f40-819d-32240dd9efee" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0d06dc56-e85b-4fda-a6e2-e8101876c028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25f52d8-3119-4f5e-a8e8-7f5153f1a899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9e578090-d5b0-4852-b8f7-9819b9e72199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25f52d8-3119-4f5e-a8e8-7f5153f1a899" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9e578090-d5b0-4852-b8f7-9819b9e72199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_650a1036-626c-4a3a-9a14-073941858405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25f52d8-3119-4f5e-a8e8-7f5153f1a899" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_650a1036-626c-4a3a-9a14-073941858405" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_ProceedsFromSaleOfCommonStock_3ad10dfc-1901-4fb3-ba24-8655e522e461" xlink:href="vtvt-20221231.xsd#vtvt_ProceedsFromSaleOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25f52d8-3119-4f5e-a8e8-7f5153f1a899" xlink:to="loc_vtvt_ProceedsFromSaleOfCommonStock_3ad10dfc-1901-4fb3-ba24-8655e522e461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_16455718-4606-47e7-91e5-42c240ffa432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25f52d8-3119-4f5e-a8e8-7f5153f1a899" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_16455718-4606-47e7-91e5-42c240ffa432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a5c0dc68-9841-4e3d-ab5e-3f0f2bf8cf79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25f52d8-3119-4f5e-a8e8-7f5153f1a899" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a5c0dc68-9841-4e3d-ab5e-3f0f2bf8cf79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants_3e386a9b-75ac-4c02-b05a-8cac809f4265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25f52d8-3119-4f5e-a8e8-7f5153f1a899" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants_3e386a9b-75ac-4c02-b05a-8cac809f4265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_ProceedsFromIssuanceOfCommonStockToRelatedParty_218275c9-dfbf-473b-aa02-6cd36c1ab2a7" xlink:href="vtvt-20221231.xsd#vtvt_ProceedsFromIssuanceOfCommonStockToRelatedParty"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25f52d8-3119-4f5e-a8e8-7f5153f1a899" xlink:to="loc_vtvt_ProceedsFromIssuanceOfCommonStockToRelatedParty_218275c9-dfbf-473b-aa02-6cd36c1ab2a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b7805e6c-3f59-40c4-9ded-2c753fea08fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b7805e6c-3f59-40c4-9ded-2c753fea08fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_f3770258-dfa6-42d8-bad6-6d7048df76c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_f3770258-dfa6-42d8-bad6-6d7048df76c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a31f1dbb-ffa9-4e7a-a01b-7a43f9539485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a31f1dbb-ffa9-4e7a-a01b-7a43f9539485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2416a0d9-9f90-4092-a4ba-6eabdf856ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_ProfitLoss_2416a0d9-9f90-4092-a4ba-6eabdf856ed8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_79c57e21-70fe-4b41-91c4-86e2e458ce43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_79c57e21-70fe-4b41-91c4-86e2e458ce43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_19d10ce2-97f0-4c72-86de-ca1ae36ac822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_InterestIncomeOperating_19d10ce2-97f0-4c72-86de-ca1ae36ac822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6e807241-c2f2-4250-9014-c7aaef69b63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_Depreciation_6e807241-c2f2-4250-9014-c7aaef69b63a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther_5ac79a3b-226b-4d21-acc8-bdb34cba6157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_InterestExpenseOther_5ac79a3b-226b-4d21-acc8-bdb34cba6157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_AccretedInterestOnDebt_8d2e8ccf-e26a-4a11-8eec-5b232b60d34c" xlink:href="vtvt-20221231.xsd#vtvt_AccretedInterestOnDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_vtvt_AccretedInterestOnDebt_8d2e8ccf-e26a-4a11-8eec-5b232b60d34c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_ac9efc61-697e-41bc-9d50-f9ed752a45e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_ac9efc61-697e-41bc-9d50-f9ed752a45e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ecddeb69-df8e-4b79-a425-7e5404850421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_ShareBasedCompensation_ecddeb69-df8e-4b79-a425-7e5404850421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fd5435ef-975f-4fe6-a7c0-7a418cfd8c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fd5435ef-975f-4fe6-a7c0-7a418cfd8c85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_ChangeInFairValueOfWarrantsRelatedParty_56e71bdd-3b5d-4ed2-9558-6a09c17fa5d8" xlink:href="vtvt-20221231.xsd#vtvt_ChangeInFairValueOfWarrantsRelatedParty"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_vtvt_ChangeInFairValueOfWarrantsRelatedParty_56e71bdd-3b5d-4ed2-9558-6a09c17fa5d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_430cfdde-e9a2-49e9-916f-1fe643721814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_430cfdde-e9a2-49e9-916f-1fe643721814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_IncreaseDecreaseInLongTermDeposits_68e4ecd5-14b6-43b2-8b15-36600e0c2b2b" xlink:href="vtvt-20221231.xsd#vtvt_IncreaseDecreaseInLongTermDeposits"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fbf68d6-a4cf-40eb-825e-7b68d0197548" xlink:to="loc_vtvt_IncreaseDecreaseInLongTermDeposits_68e4ecd5-14b6-43b2-8b15-36600e0c2b2b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/CollaborationAgreementsSummaryofContractLiabilitiesRelatedtoCompanysCollaborationAgreementsDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#CollaborationAgreementsSummaryofContractLiabilitiesRelatedtoCompanysCollaborationAgreementsDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/CollaborationAgreementsSummaryofContractLiabilitiesRelatedtoCompanysCollaborationAgreementsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_799d6d81-ef6d-4f90-a1a4-6439ec632728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a49f435c-bff1-4c2f-8f7f-494c09ef3640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_799d6d81-ef6d-4f90-a1a4-6439ec632728" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a49f435c-bff1-4c2f-8f7f-494c09ef3640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_9b0b4800-9f7f-44c8-8579-a97c3023f481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_799d6d81-ef6d-4f90-a1a4-6439ec632728" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_9b0b4800-9f7f-44c8-8579-a97c3023f481" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/PrepaidExpensesandOtherCurrentAssetsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#PrepaidExpensesandOtherCurrentAssetsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/PrepaidExpensesandOtherCurrentAssetsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3efa0462-c436-4c8f-8b0b-df7b4aec988a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_4238c63f-be6a-4f41-bd6d-63348d920e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3efa0462-c436-4c8f-8b0b-df7b4aec988a" xlink:to="loc_us-gaap_PrepaidInsurance_4238c63f-be6a-4f41-bd6d-63348d920e92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_f0e0cd98-0ef5-4545-b5dd-69a5355556c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3efa0462-c436-4c8f-8b0b-df7b4aec988a" xlink:to="loc_us-gaap_PrepaidTaxes_f0e0cd98-0ef5-4545-b5dd-69a5355556c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_103158db-ce89-402f-bb3e-6be5bd43bf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3efa0462-c436-4c8f-8b0b-df7b4aec988a" xlink:to="loc_us-gaap_DeferredCostsCurrent_103158db-ce89-402f-bb3e-6be5bd43bf96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_c4d342f5-3b36-4351-8ed1-7e2bf824a0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3efa0462-c436-4c8f-8b0b-df7b4aec988a" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_c4d342f5-3b36-4351-8ed1-7e2bf824a0ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fc50f930-ca17-4c27-b945-b0cec4856da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b62e8344-dabb-492a-952b-aa34c3467493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_fc50f930-ca17-4c27-b945-b0cec4856da6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b62e8344-dabb-492a-952b-aa34c3467493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_17375b94-240d-473d-894d-2968589eb79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_fc50f930-ca17-4c27-b945-b0cec4856da6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_17375b94-240d-473d-894d-2968589eb79e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/InvestmentsScheduleofEquityInvestmentswithandwithoutReadilyDeterminableFairValuesAssessedDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#InvestmentsScheduleofEquityInvestmentswithandwithoutReadilyDeterminableFairValuesAssessedDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/InvestmentsScheduleofEquityInvestmentswithandwithoutReadilyDeterminableFairValuesAssessedDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_a40246ac-7186-45f0-a5fa-b423ce837c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_cb6e6e2d-0c92-4549-a204-6bc5d8c7fe54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermInvestments_a40246ac-7186-45f0-a5fa-b423ce837c91" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_cb6e6e2d-0c92-4549-a204-6bc5d8c7fe54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_be211f84-3196-46e8-854b-e53252e39045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermInvestments_a40246ac-7186-45f0-a5fa-b423ce837c91" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_be211f84-3196-46e8-854b-e53252e39045" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/AccountsPayableandAccruedExpensesScheduleofAccountsPayableandAccruedLiabilitiesDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#AccountsPayableandAccruedExpensesScheduleofAccountsPayableandAccruedLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/AccountsPayableandAccruedExpensesScheduleofAccountsPayableandAccruedLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ae453798-4093-4685-9ce9-a93958f0936b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c2859a82-1f19-4540-925a-8ca6a9fcbd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ae453798-4093-4685-9ce9-a93958f0936b" xlink:to="loc_us-gaap_AccountsPayableCurrent_c2859a82-1f19-4540-925a-8ca6a9fcbd29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_AccruedDevelopmentCostsCurrent_d2ce0709-37e5-477c-9445-8b0e81c448c6" xlink:href="vtvt-20221231.xsd#vtvt_AccruedDevelopmentCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ae453798-4093-4685-9ce9-a93958f0936b" xlink:to="loc_vtvt_AccruedDevelopmentCostsCurrent_d2ce0709-37e5-477c-9445-8b0e81c448c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_AccruedCompensationAndRelatedCosts_bfb0024d-25f4-4b79-a91c-4dc67781a271" xlink:href="vtvt-20221231.xsd#vtvt_AccruedCompensationAndRelatedCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ae453798-4093-4685-9ce9-a93958f0936b" xlink:to="loc_vtvt_AccruedCompensationAndRelatedCosts_bfb0024d-25f4-4b79-a91c-4dc67781a271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c929c322-7501-4959-900b-b73352774c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ae453798-4093-4685-9ce9-a93958f0936b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c929c322-7501-4959-900b-b73352774c57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesforOperatingLeasesDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesforOperatingLeasesDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesforOperatingLeasesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4953e70b-1576-47e1-9830-e80c19c142b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8c41c25e-cf26-47d0-89f4-cc3716aa902e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4953e70b-1576-47e1-9830-e80c19c142b8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8c41c25e-cf26-47d0-89f4-cc3716aa902e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_be937a0d-9020-4f06-8e7c-e4a4931db3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4953e70b-1576-47e1-9830-e80c19c142b8" xlink:to="loc_us-gaap_OperatingLeaseLiability_be937a0d-9020-4f06-8e7c-e4a4931db3e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesforOperatingLeasesDetail_1" xlink:type="simple" xlink:href="vtvt-20221231.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesforOperatingLeasesDetail_1"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesforOperatingLeasesDetail_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d217216-ee0e-4ee4-8e0d-e73fef929239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fd56c0e4-04c9-4842-b86d-7cebdaa7fb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d217216-ee0e-4ee4-8e0d-e73fef929239" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fd56c0e4-04c9-4842-b86d-7cebdaa7fb0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_160d188a-410d-427a-b520-d2529fe90ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d217216-ee0e-4ee4-8e0d-e73fef929239" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_160d188a-410d-427a-b520-d2529fe90ab8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5ce2b03b-72b6-4ef6-afb2-7bb3de29b971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d217216-ee0e-4ee4-8e0d-e73fef929239" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5ce2b03b-72b6-4ef6-afb2-7bb3de29b971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c2a71849-ba90-4650-b132-484a212602b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d217216-ee0e-4ee4-8e0d-e73fef929239" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c2a71849-ba90-4650-b132-484a212602b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_09a073ea-bba7-4219-8cc3-27be6137cc71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d217216-ee0e-4ee4-8e0d-e73fef929239" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_09a073ea-bba7-4219-8cc3-27be6137cc71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_018cf723-d6b0-4c57-be18-3e0a1db01a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d217216-ee0e-4ee4-8e0d-e73fef929239" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_018cf723-d6b0-4c57-be18-3e0a1db01a36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/NotesPayableScheduleofNotesPayableDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#NotesPayableScheduleofNotesPayableDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/NotesPayableScheduleofNotesPayableDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_b2b18425-83db-41e0-b729-27f7d2b5c9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_e87a16f7-66fe-461b-ace6-b205055195d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesPayable_b2b18425-83db-41e0-b729-27f7d2b5c9de" xlink:to="loc_us-gaap_LongTermNotesPayable_e87a16f7-66fe-461b-ace6-b205055195d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_562c612e-befc-4675-99c4-11ad12d61081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesPayable_b2b18425-83db-41e0-b729-27f7d2b5c9de" xlink:to="loc_us-gaap_NotesPayableCurrent_562c612e-befc-4675-99c4-11ad12d61081" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/RedeemableNoncontrollingInterestSummaryofNetIncomeAttributabletoVtvTherapeuticsIncDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#RedeemableNoncontrollingInterestSummaryofNetIncomeAttributabletoVtvTherapeuticsIncDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/RedeemableNoncontrollingInterestSummaryofNetIncomeAttributabletoVtvTherapeuticsIncDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_a71dbaa4-9742-4253-b83a-4f412bce8847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_367886b6-862d-45cf-b157-0fe05362bdba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_a71dbaa4-9742-4253-b83a-4f412bce8847" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_367886b6-862d-45cf-b157-0fe05362bdba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_6c52e1c5-5323-4abf-b658-fc271e6f5b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_a71dbaa4-9742-4253-b83a-4f412bce8847" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_6c52e1c5-5323-4abf-b658-fc271e6f5b84" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_427dd36d-007e-4f6c-8040-5eb1d92da569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_63e2325c-2569-4e42-841a-f7edcdfa9f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_427dd36d-007e-4f6c-8040-5eb1d92da569" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_63e2325c-2569-4e42-841a-f7edcdfa9f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_IncomeTaxReconciliationPartnershipIncomeFederalNotSubjectToTax_afeb6664-2795-4d08-b273-124adf4c8773" xlink:href="vtvt-20221231.xsd#vtvt_IncomeTaxReconciliationPartnershipIncomeFederalNotSubjectToTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_427dd36d-007e-4f6c-8040-5eb1d92da569" xlink:to="loc_vtvt_IncomeTaxReconciliationPartnershipIncomeFederalNotSubjectToTax_afeb6664-2795-4d08-b273-124adf4c8773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_IncomeTaxReconciliationForeignWithholdingTax_f8c2d012-18cc-4cdf-b989-781321d594ef" xlink:href="vtvt-20221231.xsd#vtvt_IncomeTaxReconciliationForeignWithholdingTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_427dd36d-007e-4f6c-8040-5eb1d92da569" xlink:to="loc_vtvt_IncomeTaxReconciliationForeignWithholdingTax_f8c2d012-18cc-4cdf-b989-781321d594ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_12b43890-d050-4017-ba14-4c50e7ec103f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_427dd36d-007e-4f6c-8040-5eb1d92da569" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_12b43890-d050-4017-ba14-4c50e7ec103f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_2c1c3d07-c107-430f-a887-811079f0b4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_427dd36d-007e-4f6c-8040-5eb1d92da569" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_2c1c3d07-c107-430f-a887-811079f0b4cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_0fbd6e46-baaf-4b51-b022-c1f9da68e552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_427dd36d-007e-4f6c-8040-5eb1d92da569" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_0fbd6e46-baaf-4b51-b022-c1f9da68e552" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8796fade-5e74-4b1e-b33c-71a5c5d43e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_427dd36d-007e-4f6c-8040-5eb1d92da569" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8796fade-5e74-4b1e-b33c-71a5c5d43e15" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/IncomeTaxesScheduleofNetDeferredTaxAssetsLiabilitiesDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#IncomeTaxesScheduleofNetDeferredTaxAssetsLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/IncomeTaxesScheduleofNetDeferredTaxAssetsLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_28e1c26d-f048-416d-acfe-e12588a45ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0092abbf-bbef-4aac-98dc-3b5e77249d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_28e1c26d-f048-416d-acfe-e12588a45ac4" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_0092abbf-bbef-4aac-98dc-3b5e77249d9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_09c13a30-5822-4c7b-8d11-775d2ea1757a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_28e1c26d-f048-416d-acfe-e12588a45ac4" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_09c13a30-5822-4c7b-8d11-775d2ea1757a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2fa19ad2-98c2-48b4-be26-af8fd5a29df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_be56cdf6-ca85-47d9-9124-88d25650deeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2fa19ad2-98c2-48b4-be26-af8fd5a29df5" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_be56cdf6-ca85-47d9-9124-88d25650deeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1a227d2b-79c3-42d3-b9d1-19937ecf31ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2fa19ad2-98c2-48b4-be26-af8fd5a29df5" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1a227d2b-79c3-42d3-b9d1-19937ecf31ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_2db3a7d3-5685-4311-a8fe-8a3c6609eeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2fa19ad2-98c2-48b4-be26-af8fd5a29df5" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_2db3a7d3-5685-4311-a8fe-8a3c6609eeaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_8d9866b9-18a5-4fee-a14e-f65feb578314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2fa19ad2-98c2-48b4-be26-af8fd5a29df5" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_8d9866b9-18a5-4fee-a14e-f65feb578314" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/NetLossperShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossperShareofClassACommonStockDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#NetLossperShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossperShareofClassACommonStockDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/NetLossperShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossperShareofClassACommonStockDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c28a04bf-44bd-4e09-ac28-297d9606d8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_664cfb50-d35f-4801-adf5-6287df893700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c28a04bf-44bd-4e09-ac28-297d9606d8b7" xlink:to="loc_us-gaap_NetIncomeLoss_664cfb50-d35f-4801-adf5-6287df893700" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d83692ab-063b-4ec6-9682-b71c0ade8b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_82728b5c-8682-4c48-8505-596e449ef7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d83692ab-063b-4ec6-9682-b71c0ade8b7c" xlink:to="loc_us-gaap_NetIncomeLoss_82728b5c-8682-4c48-8505-596e449ef7a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/FairValueofFinancialInstrumentsSummarizestheConclusionsReachedRegardingFairValueMeasurementsDetail" xlink:type="simple" xlink:href="vtvt-20221231.xsd#FairValueofFinancialInstrumentsSummarizestheConclusionsReachedRegardingFairValueMeasurementsDetail"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/FairValueofFinancialInstrumentsSummarizestheConclusionsReachedRegardingFairValueMeasurementsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_430a09db-fa09-41cc-857c-f8ba6944a1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_0ff6401e-8c58-4eef-9b66-70b0b75d2d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_430a09db-fa09-41cc-857c-f8ba6944a1a4" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_0ff6401e-8c58-4eef-9b66-70b0b75d2d92" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
